Table 3 Results of regression analyses: Prediction of phase (2) fMRI-RX amygdala activation by phase (1) fMRI-ER dlPFC activation and, as a control analysis, by phase (1) fMRI-ER amygdala activation, moderated by group.
Phase (2) fMRI-RX: dependent variable | |||||
|---|---|---|---|---|---|
х̅RXamygdala_L | х̅RXamygdala_R | ||||
beta ± SEM | p | beta ± SEM | p | ||
Phase (1) fMRI-ER: predictor | Left ventral dlPFC | ||||
Constant | −0.02 ± 0.26 | 0.93 | −0.14 ± 0.34 | 0.68 | |
х̅ERdlPFC_Lventral | −0.84 ± 0.53 | 0.12 | −0.49 ± 0.48 | 0.48 | |
Group | 1.15 ± 0.38 | <0.01** | 1.77 ± 0.50 | <0.001*** | |
Group*х̅ERdlPFC_Lventral | 1.51 ± 0.75 | <0.05* | 0.30 ± 0.99 | 0.77 | |
Left dorsal dlPFC | |||||
Constant | −0.07 ± 0.25 | 0.77 | −0.16 ± 0.33 | 0.64 | |
х̅ERdlPFC_Ldorsal | −1.07 ± 0.49 | <0.05* | −0.92 ± 0.65 | 0.16 | |
Group | 1.24 ± 0.36 | <0.01** | 1.65 ± 0.48 | <0.01** | |
Group*х̅ERdlPFC_Ldorsal | 1.78 ± 0.71 | <0.05* | 1.51 ± 0.95 | 0.12 | |
Right dorsal dlPFC | |||||
Constant | −0.06 ± 0.26 | 0.82 | −0.21 ± 0.35 | 0.54 | |
х̅ERdlPFC_Rdorsal | −0.35 ± 0.38 | 0.37 | −0.14 ± 0.50 | 0.78 | |
Group | 1.31 ± 0.37 | <0.001*** | 1.80 ± 0.49 | <0.001*** | |
Group *х̅ERdlPFC_Rdorsal | 0.52 ± 0.50 | 0.30 | −0.16 ± 0.65 | 0.80 | |
Right amygdala | |||||
Constant | −0.09 ± 0.26 | 0.74 | −0.15 ± 0.34 | 0.65 | |
х̅ERamygdala_R | −0.49 ± 0.96 | 0.61 | −0.73 ± 1.24 | 0.57 | |
Group | 1.39 ± 0.37 | <0.001* | 1.72 ± 0.48 | <0.001* | |
Group *х̅ERamygdala_R | −0.06 ± 1.20 | 0.96 | 1.09 ± 1.56 | 0.49 | |